Verano Holdings Corp. (VRNOF)
Verano Holdings Corp. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Chicago, IL, US. The stock last traded at $1.30, up 8.33% on the session, giving a market capitalisation of $470.4M. On trailing twelve-month figures it carries a trailing P/E of -2.03, a net margin of -36.6%. Its beta of 1.67 implies it has historically moved more than the broad market.
Verano Holdings Corp. functions as a comprehensive, multi-state cannabis enterprise based in the United States. Its operations cover the entire cannabis supply chain, from cultivation and processing to wholesale and retail distribution. The company maintains a presence in numerous states, including Arizona, Arkansas, California, Connecticut, Florida, Illinois, Maryland, Massachusetts, Michigan, Missouri, Nevada, New Jersey, Ohio, Pennsylvania, and West Virginia. Verano offers a range of artisanal cannabis products under brands such as Encore, Avexia, MUV, and Verano, catering to both medical and adult-use markets. As of May 10, 2022, it managed 96 retail dispensaries and 13 cultivation and processing facilities. The corporate headquarters are located in Chicago, Illinois.
Verano Holdings Corp. is most often compared with the following Healthcare names: